BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, January 18, 2026
See today's BioWorld Asia
Home
» OctoPlus Shares Surge After Dr. Reddy's $36M Buyout Bid
To read the full story,
subscribe
or
sign in
.
OctoPlus Shares Surge After Dr. Reddy's $36M Buyout Bid
Oct. 24, 2012
By
Cormac Sheridan
The management of Dutch drug delivery specialist OctoPlus NV agreed to a €27.4 million (US$35.8 million) cash offer from Indian generics firm Dr. Reddy's Laboratories Ltd.
BioWorld Asia
